INS and diabetes mellitus: Reasons for withdrawal for the 25 patients that did not complete the 90-day visit included (1) withdrawn consent (n=12; 48%); (2) lost to follow-up (n=10; 40%); (3) switched insulin types to unsupported insulin (n=2; 8%); and (4) experienced a health complication unrelated to diabetes (n=1; 4%).